Target intelligence / Profile preview

TMEM254 antisense RNA 1 (TMEM254-AS1)

Target: TMEM254-AS1
Molecular classification: Long non-coding RNA (lncRNA), Other

Overview

TMEM254 antisense RNA 1 (TMEM254-AS1), also known as CPHX, is classified as a long non-coding RNA (lncRNA) and is not a protein-coding gene[1][2][8]. It is identified in genomic resources, but there is no evidence that it acts as a traditional drug target such as a receptor, enzyme, transporter, or transcription factor[2][8]. Its biological function, disease relevance, interacting drugs, mechanisms of action, biomarker utility, and safety concerns have not been characterized in accessible literature as of the current date[2][8].

Other names: CPHXGC10M081807GC10M080046

Mechanism of action

None known

Biological functions

Other

Disease associations

Other

Beyond the preview

Go deeper on TMEM254 antisense RNA 1 (TMEM254-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMEM254 antisense RNA 1 (TMEM254-AS1).

Explore the full profile